Generic Duexis

A patent currently prevents generic versions of Duexis (ibuprofen/famotidine) from being sold. The patent is set to expire in July 2026, which is the earliest predictable date that a generic Duexis product could become available. However, new patents for specific uses or lawsuits may delay the manufacturing of a generic version of this drug.

Can I Buy Generic Duexis?

Duexis™ (ibuprofen/famotidine) is a prescription medication approved for the treatment of osteoarthritis and rheumatoid arthritis. It contains ibuprofen, which is a nonsteroidal anti-inflammatory drug (NSAID), and famotidine, which is an acid-reducing medication. The famotidine is added to reduce the risk for stomach and intestinal ulcers that can occur with ibuprofen.
Duexis is made by Horizon Pharma USA, Inc. There are no generic versions of this medicine available at this time.

When Will a Generic Version Be Available?

The first patent for Duexis is set to expire in July 2026. This is the earliest predictable date that a generic version could become available. However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or patents for new Duexis uses.

What About Taking Ibuprofen and Famotidine Separately?

Whenever a new combination medication becomes available, people wonder whether the combination provides any cost savings. There are many factors that come into play (such as the pricing your pharmacy chooses and your particular insurance plan), so it can be difficult to predict whether using the combination product or taking the two drugs (ibuprofen and famotidine) separately will be less expensive.
Top Foods to Fight Inflammation

Duexis Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.